These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8147122)

  • 1. [Vaccination coverage of 2-year-old children in Geneva].
    Bouvier P; Valdez E; Toscani L; Restellini JP; Rougemont A
    Soz Praventivmed; 1994; 39(1):56-62. PubMed ID: 8147122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunization of 28 months old children in Geneva, Switzerland: trend over a 6-year period, 1995-2000].
    Golay M; Sudre P
    Soz Praventivmed; 2005; 50(5):319-23. PubMed ID: 16300176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination coverage of 2-year-old children--United States, 1992-1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Apr; 43(15):282-3. PubMed ID: 8164635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines.
    Rothstein EP; Bernstein HH; Glode MP; Laussucq S; Nonenmacher J; Long SS; Hackell JG
    Am J Dis Child; 1993 Aug; 147(8):854-7. PubMed ID: 8394646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Routine immunization of infants in the Canton of Zurich].
    Vranjes N; Gyurech D; Schilling J; Gugelmann R; Steffen R
    Schweiz Med Wochenschr; 1996 Jan; 126(1-2):22-6. PubMed ID: 8571109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential impact on vaccination coverage levels by administering vaccines simultaneously and reducing dropout rates.
    Dietz VJ; Stevenson J; Zell ER; Cochi S; Hadler S; Eddins D
    Arch Pediatr Adolesc Med; 1994 Sep; 148(9):943-9. PubMed ID: 8075738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization coverage in a population-based sample of Maryland children.
    Williams IT; Dwyer DM; Hirshorn EM; Bonito RC; Graham NM
    Arch Pediatr Adolesc Med; 1994 Apr; 148(4):350-6. PubMed ID: 8148933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to simultaneous administration of a combined measles, mumps and rubella vaccine with booster doses of diphtheria-tetanus and poliovirus vaccine.
    Giammanco G; Li Volti S; Salemi I; Giammanco Bilancia G; Mauro L
    Eur J Epidemiol; 1993 Mar; 9(2):199-202. PubMed ID: 8519358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
    Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.
    Deforest A; Long SS; Lischner HW; Girone JA; Clark JL; Srinivasan R; Maguire TG; Diamond SA; Schiller RP; Rothstein EP
    Pediatrics; 1988 Feb; 81(2):237-46. PubMed ID: 3340474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of missed opportunities to vaccinate preschool-aged children on vaccination coverage levels--selected U.S. sites, 1991-1992.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Oct; 43(39):709-18. PubMed ID: 8090159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of vaccine coverage from school year 2003-2004 to 2006-2007, for 5 to 6-year-old children in Geneva].
    Jeannot E; Wyler Lazarevic CA; Duperrex O; Chastonay P
    Med Mal Infect; 2010 Jan; 40(1):27-30. PubMed ID: 19615837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating vaccination coverage using parental recall, vaccination cards, and medical records.
    Bolton P; Holt E; Ross A; Hughart N; Guyer B
    Public Health Rep; 1998; 113(6):521-6. PubMed ID: 9847923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with improved immunization rates for urban minority preschool children.
    Mitchell CK; Franco SM
    Clin Pediatr (Phila); 1995 Sep; 34(9):466-70. PubMed ID: 7586918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From the Centers for Disease Control and Prevention. Impact of missed opportunities to vaccinate preschool-aged children on vaccination coverage levels--selected U.S. sites, 1991-1992.
    JAMA; 1994 Nov; 272(17):1317-8. PubMed ID: 7933382
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving child survival through immunisation.
    Lamabadusuriya SP
    Ceylon Med J; 1993 Dec; 38(4):170-1. PubMed ID: 8143330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current immunization practices. 1. Polio, diphtheria, tetanus, pertussis, measles, mumps, rubella, and influenza.
    Gillum JE; Garrison MW; Crossley KB; Rotschafer JC
    Postgrad Med; 1989 Feb; 85(2):183-6, 188-90, 195-8. PubMed ID: 2783777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.
    Farrington P; Pugh S; Colville A; Flower A; Nash J; Morgan-Capner P; Rush M; Miller E
    Lancet; 1995 Mar; 345(8949):567-9. PubMed ID: 7619183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.